Author | Julian Adams, PhD | OncLive

Author | Julian Adams, PhD

Articles

Julian Adams on the IPI-145 Mechanism of Action

June 26, 2013

Video

Julian Adams, PhD, from Infinity Pharmaceuticals, describes the mechanism of action for the experimental PI3 kinase delta/gamma inhibitor IPI-145 in hematologic malignancies.

x